Nasdaq
GANX
Gain Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- −1.1%
- 1 month
- −1.7%
- 1 year
- +15.2%
$1.78 · Mkt cap $75.9M
At the 6 Aug 2026 close
Nasdaq
Gain Therapeutics, Inc.
$1.78 · Mkt cap $75.9M
At the 6 Aug 2026 close
Gain Therapeutics, Inc. trades under the ticker GANX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $75.9M. The last closing price was $1.78, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +15.2%, and −1.7% over the past month. Returns are price returns and exclude dividends.
This page exists because GANX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.